key: cord-0908439-5gydpvkz authors: Mohapatra, Ranjan K.; Dhama, Kuldeep; El–Arabey, Amr Ahmed; Sarangi, Ashish K.; Tiwari, Ruchi; Emran, Talha Bin; Azam, Mohammad; Al-Resayes, Saud I.; Raval, Mukesh K.; Seidel, Veronique; Abdalla, Mohnad title: Repurposing benzimidazole and benzothiazole derivatives as potential inhibitors of SARS-CoV-2: DFT, QSAR, molecular docking, molecular dynamics simulation, and in-silico pharmacokinetic and toxicity studies date: 2021-10-07 journal: J King Saud Univ Sci DOI: 10.1016/j.jksus.2021.101637 sha: bd50380bddb48ec9e3db55e9de0cc8407a69a9db doc_id: 908439 cord_uid: 5gydpvkz Density Functional Theory (DFT) and Quantitative Structure-Activity Relationship (QSAR) studies were performed on four benzimidazoles (compounds 1-4) and two benzothiazoles (compounds 5 and 6), previously synthesized by our group. The compounds were also investigated for their binding affinity and interactions with the SARS-CoV-2 M(pro) (PDB ID: 6LU7) and the human angiotensin-converting enzyme 2 (ACE2) receptor (PDB ID: 6M18) using a molecular docking approach. Compounds 1, 2, and 3 were found to bind with equal affinity to both targets. Compound 1 showed the highest predictive docking scores, and was further subjected to molecular dynamics (MD) simulation to explain protein stability, ligand properties, and protein-ligand interactions. All compounds were assessed for their structural, physico-chemical, pharmacokinetic, and toxicological properties. Our results suggest that the investigated compounds are potential new drug leads to target SARS-CoV-2. The current COVID-19 pandemic, caused by the highly contagious newly emerged SARS-CoV-2, is a global health threat that affects millions of people worldwide, and impacts negatively on all sectors of society (Mohapatra et al., 2020a (Mohapatra et al., , 2020b (Mohapatra et al., , 2021a . Although the fatality rate for SARS-CoV-2 (~4%) is lower compared to that of SARS-CoV (~10%) and MERS-CoV (~35%), its transmission rate is much higher than that of previously reported coronaviruses (CoVs) (Guo et al., 2020) . In many countries, this led to lockdown measures being put into place to minimize human-to-human transmission (Mohapatra et al., 2021b) . COVID-19 related deaths have now surpassed those from other epidemics caused by pathogens such as influenza A & B, Zika, Ebola and other CoVs (Mahal et al., 2021) and declared global pandemic (Dhama et al., 2020a) . The SARS-CoV-2 virus is mainly transmitted through respiratory aerosols/droplets, and to some extent via the fecal-oral route (Chan et al., 2020; Sah et al., 2021) . Other means of transmission include direct and indirect contacts with contaminated objects/surfaces/fomites (Mohapatra et al. 2021c ; Morawska and Cao, 2020) . The SARS-CoV-2 virus primarily targets the upper and lower respiratory tract, and most people infected will experience only mild or moderate symptoms. However, in some individuals such as the elderly and/or those with pre-existing comorbidities (e.g. obesity, diabetes, cardiovascular disorders), SARS-CoV-2 infection can lead to severe complications, with multiple organ damage (Dhama et al. 2020b; Arumugam et al. 2020) . Scientists throughout the world continue to endeavor to discover and develop suitable and effective approaches to tackle this pandemic. This includes the development of vaccines such as the Covishield, Covaxin (India), AstraZeneca (UK), Moderna, Novavax (USA), Pfizer/BioNTech (Germany), Sputnik V (Russia), CanSino, Sinovac and BBIBP-CorV (China) vaccines (Madkaikar et al. 2021; Bagcchi, 2021) . Vaccination programs are underway in many countries; even if clinical efficacy against the new SARS-CoV-2 variants has yet to be established for all vaccines (Callaway, 2021) . Efforts of the scientific community have also been focused on the discovery of new antiviral drug leads. Several reports have highlighted the importance of targeting the M pro of SARS-CoV-2 -an enzyme with a pivotal role in mediating viral replication and transcription -and have used molecular docking as a promising strategy to design and develop possible M pro inhibitors (Ancy et al., 2020; Baildya et al., 2020; Mohapatra et al., 2021d) . Another aim has been to target virus entry mechanisms via disruption of the interaction of SARS-CoV-2 with the human ACE2 receptor responsible for viral attachment to the host cells (Rezaei et al., 2021; Joshi et al., 2020) . In this work, we used a comprehensive in-silico approach, including molecular docking and MD simulation studies, to investigate the predictive binding affinity of four benzimidazoles and two benzothiazoles previously synthesized by our group (Mohapatra et al., 2011 (Mohapatra et al., , 2018 towards SARS-CoV-2 M pro and the human ACE2 receptor. We also report on the pharmacokinetic, drug-likeness, and toxicological properties of the studied compounds. DFT is a computational modeling study used to investigate the electronic structure of molecules. The DFT analysis was carried out through GAUSSIAN inter phase. All compounds were first optimized using the Gauss View 6.0.16 program (Gauss View 6.0, 2019), and then subjected to DFT calculation using the GAUSSIAN 09 suite programs (Frisch et al., 2009 ). The computation was performed using the B3LYP method and (Table S1) . (Table S2) . We observed that the chemical softness (S) of compound 4 was lesser than the other compounds, indicating a higher stability for compound 4. Another important parameter is the electrophilicity ( ) of compounds, which assesses its ability to accept ω electron(s) from its surrounding. Compound 1 showed less electrophilicity than other compounds (Table S2) QSAR modelling was used to characterize the physico-chemical properties of the investigated compounds and predict their correlations to biological activity. QSAR studies were performed using the Hyper Chem Professional 8.0.3 program. First, the structure of each compound was optimized with a semi-empirical PM3 method using a (MM + ) force field, and then energy minimization was achieved using a Fletcher-Reeves conjugate gradient algorithm. A range of QSAR parameters including free energy, hydration energy, total energy, refractivity, surface area, volume, polarizability, mass, dipole moment, partition coefficient (log P), and RMS gradient were calculated. Interestingly, the log P value for compound 5 was the highest amongst all compounds, indicating the ability for this compound to efficiently permeate biological membranes (Mohapatra et al., 2021d) ( Table 1) . The docking analysis was executed using a receptor-oriented flexible docking protocol with the Autodock 4.2.6 software package and Python 3.8.2. The ligands were generated with MGL Tools 1.5.6 and optimized using the Avogadro program. The 3D X-ray structure for SARS-CoV-2 M pro and the ACE2 receptor was retrieved from the Protein Data Bank Table S3 . Compound-1 formed H-bonds with Thr199 (OG1), Leu287 (O), and ionic interactions with Asp289 (OD1, OD2) (Fig. 2) . Interactions with Thr199, Leu287 and Asp289 were observed for all compounds. When docked with the human ACE2 receptor (PDB ID: 6M18), compound-1 showed ionic interactions with Asp494 (OD1), H-bonding with His493, and pi-pi interaction with Arg671 (Table S4) . Interactions with His493, Asp494 and Arg671 were observed for almost all compounds. value of M pro (6LU7) and ACE2 (6M18) at equilibrium was found to be 1.8 and 9.5 Å, respectively (Fig. 4) . The deviation within 1-3 Å is acceptable for small globular protein. Based on these results, the (Comp.1-6LU7) and (Comp.1-6M18) complexes were further analyzed for protein-ligand contacts. These were around 290 to 300 Å 2 (equilibrium~295 Å 2 ), and around 285 to 295 Å 2 (equilibrium ~293 Å 2 ) for Comp.1-6LU7 and Comp.1-6M18, respectively. The SASA values fluctuated slightly until 5 and 25 ns for Comp.1-6LU7 and Comp.1-6M18, respectively, before gradually reaching an equilibrium. These were around 160 to 320 Å 2 (equilibrium~210 Å 2 ), and around 60 to 240 Å 2 (equilibrium ~ 80 Å 2 ) for Comp.1-6LU7 and Comp.1-6M18, respectively. The PSA values were constant throughout the simulation. These were around 84 to 102 Å 2 (equilibrium ~96 Å 2 ), and around 88 to 112 Å 2 (equilibrium ~ 96 Å 2 ) for Comp.1-6LU7 and Comp.1-6M18, respectively ( Fig. 5 & 6 ). In both cases, the ligand showed minimal fluctuation in the initial part of the simulation period, then gradually reached equilibrium which remained constant throughout the simulation, suggesting they possessed good stability in the active site of both proteins. The protein-ligand (P-L) contacts of the (Comp.1-6LU7) and (Comp.1-6M18) complexes were studied using contact histograms (Dariya and Nagaraju, 2020) . The P-L interactions were classified into four types such as hydrophobic, ionic, water bridges, and hydrogen bonds. The latter are commonly grouped into four sub-types such as side-chain acceptor, side-chain donor, backbone donor and backbone acceptor. They play a crucial role in ligand-protein binding and are essential to take into account when it comes to the design of new drugs. The histograms identified Leu-675 as the H-bond interacting amino acid residues for the (Comp.1-6LU7) and (Comp.1-6M18) complexes, respectively. The hydrophobic contacts, involving a hydrophobic amino acid and an aromatic or aliphatic group on the ligand, were characterized as pi-cation, pi-pi and other non-specific interactions. The amino acids that showed hydrophobic interactions with the ligand included Tyr-237, , Leu-675 for 6M18. We observed that Asp-494 showed minimal ionic interactions with the ligand for 6M18. Most of the interacting amino acids for 6M18) showed water bridges with the ligand (Fig. 7 & 8 ). An overview of all protein-ligand interactions is summarized in Fig. 7 Knowledge of the pharmacokinetic and drug-likeness properties of newly designed ligands for specific targets is essential to predict the absorption, distribution, metabolism, and excretion of potential new drug leads (Shivanika et al., 2020; Savale et al., 2021) . In this study, pharmacokinetic properties predictions for the investigated compounds ( Fig. 9 ) were carried out using the admetSAR (versions 1 and 2) and SwissADME software. Their Lipinski's properties were determined using physico-chemical data retrieved from the PubChem database. We observed that all compounds obeyed the Lipinski's rule of five, with molecular weights ˂ 500 g/mol, number of hydrogen bond donors and acceptors ˂ 5, logP value ˂ 5 and molar refractivity < 140 (Lipinski, 2000 (Lipinski, , 2004 . The Topological Polar Surface Area (TPSA) of all compounds was <90 Å 2 , indicating their ability to permeate biological membranes (Shivanika et al., 2020; Dariya and Nagaraju, 2020) . Moreover, all compounds showed good solubility and high gastrointestinal absorption. Their low number of rotatable bonds (3 or 4) suggested a good flexibility. The synthetic accessibility value of all compounds was ≤ 3, which indicated the feasibility of synthesis (Table S5 -S11). The toxicity of the investigated compounds was also evaluated using the pkCSM software tool (http://structure.bioc.cam.ac.uk/pkcsm) (Table S10) . We observed that the compounds were neither hepatotoxic nor carcinogenic, and that compound 4 and 6 showed better toxicity results. Four benzimidazole and two benzothiazole derivatives were investigated for their binding affinity for M pro and ACE2 receptor using a molecular docking approach. Compounds 1, 2, and 3 were found to bind with equal affinity to both targets, which may be more effective in clinical practice. One of the benzimidazoles (compound 1) was further subjected to molecular dynamics simulation to explain protein-ligand complex stability, ligand properties, and protein-ligand contacts. We established that all compounds obeyed the Lipinski's rule of five and showed good solubility, high gastrointestinal absorption, good ability to permeate biological membranes, good synthetic accessibility, and low toxicity. Taken altogether, these data suggest that the investigated compounds have the potential to combat SARS-CoV-2. We hope that this work will provide scope for further studies to establish the potential of benzimidazole and benzothiazole derivatives as new M pro and/or ACE2 receptor inhibitors. Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV CAFDs-based functional foods as a potential alternative approach to combat COVID-19 Possibility of HIV-1 protease inhibitorsclinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study COVID-19 and the World with Co-Morbidities of Heart Disease, Hypertension and Diabetes The world's largest COVID-19 vaccination campaign Inhibitory activity of hydroxychloroquine on COVID-19 main protease: An insight from MD simulation studies Could new COVID variants undermine vaccines? Labs scramble to find out A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancerpatients Coronavirus Disease 2019-COVID-19 An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies Transition Metal Complexes of (E)-2((2-hydroxybenzylidene) amino-3-mercaptopropanoic acid: XRD, Anticancer, Molecular modeling and Molecular Docking Studies GAUSIAN 09 The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking Antifungal screening and molecular docking simulation of silica supported synthesized sitosteryl hydrogen phthalate using microwave irradiation Drug-like properties and the causes of poor solubility and poor permeability Lead-and drug-like compounds: the rule-of-five revolution India's crusade against COVID-19 Recent progress in chemical approaches for thedevelopment of novel neuraminidase inhibitors Synthesis, characterisation, XRD, molecular modelling and potential antibacterial studies of Co(II) Cd(II) and Hg(II) complexes with bidentate azodye ligand Synthesis, spectral, thermal, kinetic and antibacterial studiesof transition metal complexes with benzimidazolyl-2-hydrazones of o-hydroxyacetophenone,o-hydroxybenzophenone and ovanillin Challenges in controlling COVID-19 in migrants in Odisha Infection capability of SARS-CoV-2 on different surfaces COVID-19, WHO guidelines, pedagogy, and respite Synthesis and characterization of transition metal complexes with benzimidazolyl-2-hydrazones of o-anisaldehyde and furfural Computational investigations of three main drugs and their comparison with synthesized compounds as potent inhibitors of SARS-CoV-2 main protease (Mpro): DFT, QSAR, molecular docking, and in silico toxicity analysis The recent challenges of highly contagious COVID-19; causing respiratory infections: symptoms, diagnosis, transmission, possible vaccines, animal models and immunotherapy Asia's largest slum situated in Mumbai? Anti-Infective Agents Airborne transmission of SARS-CoV-2: The world should face the reality Peptide-like and small-molecule inhibitors against Covid-19 ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID-19 The COVID-19 vaccination campaign in Nepal, emerging UK variant and futuristic vaccination strategies to combat the ongoing pandemic Synthesis and characterization of some binuclear metal complexes with a pentadentate azodye ligand: an experimental and theoretical study Synthesis and characterization of tetranuclear metal complexes with an octadentate azodye ligand Pharmacoinformatics approach based identification of potential Nsp15 endoribonuclease modulators for SARS-CoV-2 inhibition Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease Structural, spectral analysis and DNA studies of heterocyclic thiosemicarbazone ligand and its Cr(III) Hg(II), and U(VI) complexes The authors acknowledge the financial support through Researchers Supporting Project number (RSP-2021/147), King Saud University, Riyadh, Saudi Arabia. This work was supported by Shandong University postdoctoral fellowship to Mohnad Abdalla. All authors are thankful to their respective Institutions for the support they received. No known conflict of interest.